{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:33:03Z","timestamp":1794893583720,"version":"4.9.1"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009169","name":"Assiut University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009169","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cancer is a multifactorial disease influenced by complex interactions between genetic, environmental, and microbial factors. Growing evidence demonstrates that several bacterial species contribute to carcinogenesis through chronic inflammation, production of genotoxic metabolites, disruption of cell-cycle regulation, and modulation of host immune responses.\n                    <jats:italic>Helicobacter pylori<\/jats:italic>\n                    \u2013induced gastric adenocarcinoma remains the most well-established example of bacteria-driven oncogenesis; however, accumulating studies indicate that additional virulence mechanisms and bacteria-dependent pathways are also implicated in tumor initiation and progression across multiple organ systems. Given the increasing global burden of cancer and rising concerns regarding antimicrobial resistance, understanding the oncogenic roles of bacteria has become essential for guiding prevention and therapeutic strategies. This review provides a novel and integrated perspective by synthesizing mechanistic, microbiome-driven, and cross-cancer evidence on how bacterial pathogens contribute to oncogenesis, while also highlighting the shared microbial patterns observed in both gastrointestinal and extraintestinal cancers such as breast cancer. In this mini-review, we summarize the molecular mechanisms through which oncogenic bacteria facilitate cancer development, discuss microbiome dysbiosis associated with various malignancies, and examine their roles in gastric, colorectal, esophageal, lung, gallbladder, breast, and cervical cancers. Understanding these interconnected pathways may support future development of microbiome-targeted therapeutic interventions and facilitate early detection strategies.\n                  <\/jats:p>","DOI":"10.1186\/s13027-025-00722-7","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:23:29Z","timestamp":1767849809000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Bacterial contributions to cancer development: mechanisms, dysbiosis, and cross-cancer associations"],"prefix":"10.1186","volume":"21","author":[{"given":"Yasmin N.","family":"Ramadan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marah N.","family":"Alatawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah S.","family":"Albalawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helal F.","family":"Hetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"722_CR1","doi-asserted-by":"publisher","first-page":"112898","DOI":"10.1016\/j.biopha.2022.112898","volume":"149","author":"MM Rahman","year":"2022","unstructured":"Rahman MM, Islam MR, Shohag S, Ahasan MT, Sarkar N, Khan H, Hasan AM, Cavalu S, Rauf A. Microbiome in cancer: role in carcinogenesis and impact in therapeutic strategies. Biomed Pharmacother. 2022;149:112898.","journal-title":"Biomed Pharmacother"},{"key":"722_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/CEG.S243337","volume":"13","author":"L Elsalem","year":"2020","unstructured":"Elsalem L, Jum\u2019ah AA, Alfaqih MA, Aloudat O. The bacterial microbiota of gastrointestinal cancers: role in cancer pathogenesis and therapeutic perspectives. Clin And Exp Gastroenterol. 2020;13:151\u201385.","journal-title":"Clin And Exp Gastroenterol"},{"key":"722_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"722_CR4","unstructured":"WHO. 2024. \u2018Global cancer burden growing, amidst mounting need for services."},{"key":"722_CR5","volume-title":"Global cancer Observatory","author":"(IARC), International Agency for Research on Cancer","year":"2024","unstructured":"(IARC), International Agency for Research on Cancer. Global cancer Observatory. In: World Health Organization (WHO); 2024."},{"key":"722_CR6","doi-asserted-by":"publisher","first-page":"104019","DOI":"10.1016\/j.micpath.2020.104019","volume":"141","author":"S Eyvazi","year":"2020","unstructured":"Eyvazi S, Vostakolaei MA, Dilmaghani A, Borumandi O, Hejazi MS, Kahroba H, Tarhriz V. The oncogenic roles of bacterial infections in development of cancer. Microb Pathogen. 2020;141:104019.","journal-title":"Microb Pathogen"},{"key":"722_CR7","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","volume":"8","author":"de Martel","year":"2020","unstructured":"de Martel, Catherine DG, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8:e180\u201390.","journal-title":"Lancet Glob Health"},{"key":"722_CR8","volume-title":"Cancers attributable to infections","author":"(IARC), International Agency for Research on Cancer","year":"2024","unstructured":"(IARC), International Agency for Research on Cancer. Cancers attributable to infections. In: Wold Health Organization (WHO); 2024."},{"key":"722_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-4-14","volume":"4","author":"DL Mager","year":"2006","unstructured":"Mager DL. Bacteria and cancer: cause, coincidence or cure? A review. J Transl Med. 2006;4:1\u201318.","journal-title":"J Transl Med"},{"key":"722_CR10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/biology10060533","volume":"10","author":"MNA Hatta","year":"2021","unstructured":"Hatta MNA, Hanif EAM, Chin S-F, Neoh H-M. Pathogens and Carcinogenesis: a review. Biology. 2021;10:533.","journal-title":"Biology"},{"key":"722_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1128\/CMR.00012-10","volume":"23","author":"AH Chang","year":"2010","unstructured":"Chang AH, Parsonnet J. Role of bacteria in oncogenesis. Clin Microbiol Rev. 2010;23:837\u201357.","journal-title":"Clin Microbiol Rev"},{"key":"722_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.chom.2018.01.007","volume":"23","author":"L Chung","year":"2018","unstructured":"Chung L, Orberg ET, Geis AL, Chan JL, Fu K, Shields CED, Dejea CM, Fathi P, Chen J, Finard BB, Tam AJ, McAllister F, Fan H, Wu X, Ganguly S, Lebid A, Metz P, Meerbeke SWV, Huso DL, Wick EC, Pardoll DM, Wan F, Wu S, Sears CL, Housseau F. Bacteroides fragilis toxin coordinates a pro-carcinogenic inflammatory cascade via targeting of colonic epithelial cells. Cell Host Microbe. 2018;23:203\u201314.e5.","journal-title":"Cell Host Microbe"},{"key":"722_CR13","doi-asserted-by":"crossref","unstructured":"Prasad SK, Bhat S, Shashank D, R AC, Sindhu R, Rachtanapun P, Devegowda D, Santhekadur PK, Sommano SR. Bacteria-Mediated Oncogenesis and the underlying Molecular intricacies: what we know so far. Front Oncol. 2022;12.","DOI":"10.3389\/fonc.2022.836004"},{"key":"722_CR14","doi-asserted-by":"crossref","unstructured":"Hoque N, Hossain M, Rahaman M, Chowdhury R, Alam M, Hossain M, Tama R. Molecular mechanism of cell signaling pathways of cancer cells in forward and reverse mutation: a perspective review. J Cancer Tumor Int. 2024.","DOI":"10.9734\/jcti\/2024\/v14i3260"},{"key":"722_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/cells8040293","volume":"8","author":"E Mik\u00f3","year":"2019","unstructured":"Mik\u00f3 E, Kov\u00e1cs T, Seb\u0151 \u00c9, T\u00f3th J, Csonka T, Ujlaki G, Sipos A, Szab\u00f3 J, M\u00e9hes G, Bai P. Microbiome-microbial Metabolome-cancer cell interactions in breast cancer-familiar, but unexplored. Cells. 2019;8:293.","journal-title":"Cells"},{"key":"722_CR16","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.chom.2015.05.002","volume":"17","author":"T Scanu","year":"2015","unstructured":"Scanu T, Spaapen RM, Bakker JM, Pratap CB, Wu L-E, Hofland I, Broeks A, Shukla VK, Kumar M, Janssen H, Ji-Ying Song EAN-B, Riele H, Holden DW, Nath G, Neefjes J. \u2018Salmonella Manipulation of host signaling pathways provokes cellular transformation associated with gallbladder carcinoma\u2019. Cell Host Microbe. 2015;17:763\u201374.","journal-title":"Cell Host Microbe"},{"key":"722_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nrg3182","volume":"13","author":"I Cho","year":"2012","unstructured":"Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012;13:260\u201370.","journal-title":"Nat Rev Genet"},{"key":"722_CR18","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41568-023-00594-2","volume":"23","author":"E Tekle","year":"2023","unstructured":"Tekle E, Geniver, Garrett WS. Bacteria in cancer initiation, promotion and progression. Nat Rev Cancer. 2023;23:600\u201318.","journal-title":"Nat Rev Cancer"},{"key":"722_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.aaa4972","volume":"348","author":"WS Garrett","year":"2015","unstructured":"Garrett WS. Cancer and the microbiota. Science. 2015;348:80\u201386.","journal-title":"Science"},{"key":"722_CR20","doi-asserted-by":"crossref","unstructured":"Clay SL, Fonseca-Pereira D, Garrett WS. Colorectal cancer: the facts in the case of the microbiota. The J Clin Investigation. 2022;132.","DOI":"10.1172\/JCI155101"},{"key":"722_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12885-017-3234-4","volume":"17","author":"C Jacqueline","year":"2017","unstructured":"Jacqueline C, Tasiemski A, Sorci G, Ujvari B, Maachi F, Miss\u00e9 D, Renaud F, Ewald P, Thomas F, Roche B. Infections and cancer: the \u201cfifty shades of immunity\u201d hypothesis. BMC Cancer. 2017;17:257.","journal-title":"BMC Cancer"},{"key":"722_CR22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.rpor.2020.04.004","volume":"25","author":"I Piotrowski","year":"2020","unstructured":"Piotrowski I, Kulcenty K, Suchorska W. Interplay between inflammation and cancer. Rep Of Practical Oncol Radiother. 2020;25:422\u201327.","journal-title":"Rep Of Practical Oncol Radiother"},{"key":"722_CR23","doi-asserted-by":"publisher","first-page":"4070419","DOI":"10.1155\/2020\/4070419","volume":"2020","author":"SA Sheweita","year":"2020","unstructured":"Sheweita SA, Alsamghan AS. Molecular mechanisms contributing bacterial infections to the incidence of various types of cancer. Mediators Of Inflammation. 2020;2020:4070419.","journal-title":"Mediators Of Inflammation"},{"key":"722_CR24","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860\u201367.","journal-title":"Nature"},{"key":"722_CR25","doi-asserted-by":"publisher","first-page":"117398","DOI":"10.1016\/j.lfs.2020.117398","volume":"246","author":"G Laliani","year":"2020","unstructured":"Laliani G, Sorboni SG, Lari R, Yaghoubi A, Soleimanpour S, Khazaei M, Hasanian SM, Avan A. Bacteria and cancer: different sides of the same coin. Life Sci. 2020;246:117398.","journal-title":"Life Sci"},{"key":"722_CR26","first-page":"100078","volume":"2","author":"S Khatun","year":"2021","unstructured":"Khatun S, Appidi T, Rengan AK. The role played by bacterial infections in the onset and metastasis of cancer. Curr Res In Microb Sci. 2021;2:100078.","journal-title":"Curr Res In Microb Sci"},{"key":"722_CR27","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.3390\/ijms24043110","volume":"24","author":"K Yusuf","year":"2023","unstructured":"Yusuf K, Sampath V, Umar S. Bacterial infections and cancer: exploring this Association and its Implications for cancer patients. Int J Mol Sci. 2023;24:3110.","journal-title":"Int J Mol Sci"},{"key":"722_CR28","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1056\/NEJMp058270","volume":"353","author":"J Parsonnet","year":"2005","unstructured":"Parsonnet J. Clinician-discoverers-Marshall, Warren, and H. pylori. The N Engl J Med. 2005;353:2421\u201323.","journal-title":"The N Engl J Med"},{"key":"722_CR29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.canlet.2013.08.016","volume":"345","author":"F Wang","year":"2014","unstructured":"Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014;345:196\u2013202.","journal-title":"Cancer Lett"},{"key":"722_CR30","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.tim.2020.02.004","volume":"28","author":"TL Cover","year":"2020","unstructured":"Cover TL, Lacy DB, Ohi MD. The Helicobacter pylori cag type IV secretion System. Trends Microbiol. 2020;28:682\u201395.","journal-title":"Trends Microbiol"},{"key":"722_CR31","doi-asserted-by":"publisher","first-page":"e002245","DOI":"10.1161\/JAHA.115.002245","volume":"4","author":"MW Sherwood","year":"2015","unstructured":"Sherwood MW, Chiara Melloni WSJ, Washam JB, Hasselblad V, Dolor RJ. Individual Proton pump inhibitors and outcomes in patients with coronary artery disease on dual antiplatelet therapy: a systematic review. J Am Heart Assoc. 2015;4:e002245.","journal-title":"J Am Heart Assoc"},{"key":"722_CR32","doi-asserted-by":"publisher","first-page":"16188","DOI":"10.1038\/nmicrobiol.2016.188","volume":"2","author":"V K\u00f6niger","year":"2016","unstructured":"K\u00f6niger V, Holsten L, Harrison U, Busch B, Loell E, Zhao Q, Bonsor DA, Roth A, Kengmo-Tchoupa A, Smith SI, Mueller S, Sundberg EJ, Zimmermann W, Fischer W, Hauck CR, Haas R. Helicobacter pylori exploits human CEACAMs via HopQ for adherence and translocation of CagA. Nat Microbiol. 2016;2:16188.","journal-title":"Nat Microbiol"},{"key":"722_CR33","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1172\/JCI130015","volume":"130","author":"M Palrasu","year":"2020","unstructured":"Palrasu M, Zaika E, El-Rifai W, Garcia-Buitrago M, Piazuelo MB, Wilson KT, Peek RM Jr, Zaika AI. Bacterial CagA protein compromises tumor suppressor mechanisms in gastric epithelial cells. J Clin Invest. 2020;130:2422\u201334.","journal-title":"J Clin Invest"},{"key":"722_CR34","doi-asserted-by":"crossref","unstructured":"Buti L, Ruiz-Puig C, Sangberg D, Leissing TM, Brewer RC, Owen RP, Sgromo B, Royer C, Ebner D, Lu X. CagA-ASPP2 complex mediates loss of cell polarity and favors H. pylori colonization of human gastric organoids. Proceedings of the National Academy of Sciences. 2020: 2645\u201355, 117.","DOI":"10.1073\/pnas.1908787117"},{"key":"722_CR35","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1152\/physrev.00039.2009","volume":"90","author":"M Richard","year":"2010","unstructured":"Richard M, Peek CF Jr, Wilson KT. Role of innate immunity in Helicobacter pylori-induced gastric Malignancy. Physiol Rev. 2010;90:831\u201358.","journal-title":"Physiol Rev"},{"key":"722_CR36","first-page":"e10687","volume":"54","author":"MP Santos","year":"2021","unstructured":"Santos MP, Pereira JN, Delabio RW, Smith MAC, Pay\u00e3o SLM, Carneiro LC, Barbosa MS, Rasmussen LT. Increased expression of interleukin-6 gene in gastritis and gastric cancer. Braz J Med and Biol Res = Revista brasileira de pesquisas medicas e biologicas. 2021;54:e10687.","journal-title":"Braz J Med and Biol Res = Revista brasileira de pesquisas medicas e biologicas"},{"key":"722_CR37","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s12253-014-9762-1","volume":"20","author":"Y Raza","year":"2014","unstructured":"Raza Y, Khan A, Farooqui A, Mubarak M, Facista A, Akhtar SS, Khan S, Kazi JI, Bernstein C, Kazmi SU. Oxidative DNA damage as a potential early Biomarker of Helicobacter pylori associated carcinogenesis. Pathol Oncol Res. 2014;20:839\u201346.","journal-title":"Pathol Oncol Res"},{"issue":"3","key":"722_CR38","doi-asserted-by":"publisher","first-page":"Iii19","DOI":"10.1136\/gut.50.suppl_3.iii19","volume":"50","author":"M Stolte","year":"2002","unstructured":"Stolte M, Bayerd\u00f6rffer E, Morgner A, Alpen B, W\u00fcndisch T, Thiede C, Neubauer A. Helicobacter and gastric malt lymphoma. Gut. 2002;50 Suppl, 3):Iii19\u201324.","journal-title":"Gut"},{"key":"722_CR39","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3748\/wjg.v22.i2.501","volume":"22","author":"J Gagni\u00e8re","year":"2016","unstructured":"Gagni\u00e8re J, Raisch J, Veziant J, Barnich N, Bonnet R, Buc E, Bringer MA, Pezet D, Bonnet M. Gut microbiota imbalance and colorectal cancer. World J Gastroenterol. 2016;22:501\u201318.","journal-title":"World J Gastroenterol"},{"key":"722_CR40","doi-asserted-by":"publisher","first-page":"5389","DOI":"10.3390\/ijms21155389","volume":"21","author":"F Perillo","year":"2020","unstructured":"Perillo F, Amoroso C, Strati F, Giuffr\u00e8 MR, D\u00edaz-Basabe A, Lattanzi G, Facciotti F. Gut microbiota Manipulation as a tool for colorectal cancer management: recent advances in its use for therapeutic purposes. Int J Mol Sci. 2020;21:5389.","journal-title":"Int J Mol Sci"},{"key":"722_CR41","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1126\/science.aah3648","volume":"359","author":"CM Dejea","year":"2018","unstructured":"Dejea CM, Fathi P, Craig JM, Boleij A, Taddese R, Geis AL, Wu X, Shields CED, Hechenbleikner EM, Huso DL, Anders RA, Giardiello FM, Wick EC, Wang H, Wu S, Pardoll DM, Housseau F, Sears CL. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science. 2018;359:592\u201397.","journal-title":"Science"},{"key":"722_CR42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1053\/j.gastro.2004.03.054","volume":"127","author":"HM Martin","year":"2004","unstructured":"Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, Englyst H, Williams HF, Rhodes JM. Enhanced Escherichia coli adherence and invasion in Crohn\u2019s disease and colon cancer 1. Gastroenterology. 2004;127:80\u201393.","journal-title":"Gastroenterology"},{"key":"722_CR43","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Luna MA, L\u00f3pez-Briones S, Luria-P\u00e9rez R. The four horsemen in colon cancer. J Oncol. 2019, 2019;5636272.","DOI":"10.1155\/2019\/5636272"},{"key":"722_CR44","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/archsurg.139.7.760","volume":"139","author":"JS Gold","year":"2004","unstructured":"Gold JS, Bayar S, Salem RR. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic Malignancy. Archiv Surg. 2004;139:760\u201365.","journal-title":"Archiv Surg"},{"key":"722_CR45","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/carcin\/bgh091","volume":"25","author":"J Biarc","year":"2004","unstructured":"Biarc J, Nguyen IS, Pini A, Goss\u00e9 F, Richert S, Thiers\u00e9 D, Dorsselaer AV, Leize-Wagner E, Raul F, Klein J-P, Sch\u00f6ller-Guinard M.\u2019Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.Bovis)\u2019. Carcinogenesis. 2004;25:1477\u201384.","journal-title":"Carcinogenesis"},{"key":"722_CR46","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics, 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J For Clinicians. 2021;71:209\u201349.","journal-title":"CA: A Cancer J For Clinicians"},{"key":"722_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.14740\/wjon1254","volume":"11","author":"EO Then","year":"2020","unstructured":"Then EO, Lopez M, Saleem S, Gayam V, Sunkara T, Culliford A, Gaduputi V. Esophageal cancer: an updated surveillance Epidemiology and end results database analysis. World J Oncol. 2020;11:55\u201364.","journal-title":"World J Oncol"},{"key":"722_CR48","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.semcancer.2021.06.011","volume":"86","author":"MJ Mughal","year":"2022","unstructured":"Mughal MJ, Kwok HF. Multidimensional role of bacteria in cancer: mechanisms insight, diagnostic, preventive and therapeutic potential. Semin Cancer Biol. 2022;86:1026\u201344.","journal-title":"Semin Cancer Biol"},{"key":"722_CR49","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/apt.12317","volume":"37","author":"KL Blackett","year":"2013","unstructured":"Blackett KL, Siddhi SS, Cleary S, Steed H, Miller MH, Macfarlane S, Macfarlane GT, Dillon JF. \u2018Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett\u2019s and oesophageal carcinoma: association or causality?\u2019. Alimentary Pharmacol Ther. 2013;37:1084\u201392.","journal-title":"Alimentary Pharmacol Ther"},{"key":"722_CR50","doi-asserted-by":"publisher","first-page":"188388","DOI":"10.1016\/j.bbcan.2020.188388","volume":"1874","author":"A Yaghoubi","year":"2020","unstructured":"Yaghoubi A, Khazaei M, Jalili S, Hasanian SM, Avan A, Soleimanpour S, Cho WC. Bacteria as a double-action sword in cancer. Biochim Et Biophys Acta (BBA) - Rev On Cancer. 2020;1874:188388.","journal-title":"Biochim Et Biophys Acta (BBA) - Rev On Cancer"},{"key":"722_CR51","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1007\/s10620-016-4263-6","volume":"61","author":"A Sawada","year":"2016","unstructured":"Sawada A, Fujiwara Y, Nagami Y, Tanaka F, Yamagami H, Tanigawa T, Shiba M, Tominaga K, Watanabe T, Gi M, Wanibuchi H, Arakawa T. Alteration of esophageal microbiome by antibiotic treatment does not affect incidence of rat esophageal adenocarcinoma. Digestive Dis And Sci. 2016;61:3161\u201368.","journal-title":"Digestive Dis And Sci"},{"key":"722_CR52","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12885-016-2093-8","volume":"16","author":"AH Zaidi","year":"2016","unstructured":"Zaidi AH, Kelly LA, Kreft RE, Barlek M, Omstead AN, Matsui D, Boyd NH, Gazarik KE, Heit MI, Nistico L, Kasi PM, Spirk TL, Byers B, Lloyd EJ, Landreneau RJ, Jobe BA. \u2018Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma. BMC Cancer. 2016;16:52.","journal-title":"BMC Cancer"},{"key":"722_CR53","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1158\/1055-9965.EPI-13-0855","volume":"23","author":"G Yu","year":"2014","unstructured":"Yu G, Gail MH, Shi J, Klepac-Ceraj V, Paster BJ, Dye BA, Wang G-Q, Wei W-Q, Fan J-H, Qiao Y-L, Dawsey SM, Freedman ND, Abnet CC. Association between upper Digestive Tract microbiota and cancer-Predisposing States in the esophagus and stomach. Cancer Epidemiol, Biomarker Prev. 2014;23:735\u201341.","journal-title":"Cancer Epidemiol, Biomarker Prev"},{"key":"722_CR54","doi-asserted-by":"publisher","first-page":"8820","DOI":"10.1038\/srep08820","volume":"5","author":"D Nasrollahzadeh","year":"2015","unstructured":"Nasrollahzadeh D, Malekzadeh R, Ploner A, Shakeri R, Sotoudeh M, Fahimi S, Nasseri-Moghaddam S, Kamangar F, Abnet CC, Winckler B, Islami F, Boffetta P, Brennan P, Dawsey SM, Ye W. Variations of gastric corpus microbiota are associated with early esophageal squamous cell carcinoma and squamous dysplasia. Sci Rep. 2015;5:8820.","journal-title":"Sci Rep"},{"key":"722_CR55","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.micinf.2019.01.005","volume":"21","author":"F Meng","year":"2019","unstructured":"Meng F, Li R, Ma L, Liu L, Lai X, Yang D, Wei J, Ma D, Li Z. Porphyromonas gingivalis promotes the motility of esophageal squamous cell carcinoma by activating NF-\u03baB signaling pathway. Microbes And Infect. 2019;21:296\u2013304.","journal-title":"Microbes And Infect"},{"key":"722_CR56","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet (lond, Engl). 2021;398:535\u201354.","journal-title":"Lancet (lond, Engl)"},{"key":"722_CR57","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev-physiol-021115-105238","volume":"78","author":"RP Dickson","year":"2016","unstructured":"Dickson RP, Erb-Downward JR, Martinez FJ, Huffnagle GB. The microbiome and the respiratory tract. Annu Rev Physiol. 2016;78:481\u2013504.","journal-title":"Annu Rev Physiol"},{"key":"722_CR58","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ismej.2016.181","volume":"11","author":"A Remot","year":"2017","unstructured":"Remot A, Descamps D, Noordine ML, Boukadiri A, Mathieu E, Robert V, Riffault S, Lambrecht B, Langella P, Hammad H, Thomas M. Bacteria isolated from lung modulate asthma susceptibility in mice. The ISME J. 2017;11:1061\u201374.","journal-title":"The ISME J"},{"key":"722_CR59","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/2049-2618-1-19","volume":"1","author":"LN Segal","year":"2013","unstructured":"Segal LN, Alekseyenko AV, Clemente JC, Kulkarni R, Wu B, Gao Z, Chen H, Berger KI, Goldring RM, Rom WN, Blaser MJ, Weiden MD. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome. 2013;1:19.","journal-title":"Microbiome"},{"key":"722_CR60","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/LBR.0b013e31829ddf01","volume":"20","author":"C Hsu-Kim","year":"2013","unstructured":"Hsu-Kim C, Hoag JB, Cheng G-S, Lund ME. The microbiology of postobstructive pneumonia in lung cancer patients. J Bronchol Interventional Pulmonol. 2013;20:266\u201370.","journal-title":"J Bronchol Interventional Pulmonol"},{"key":"722_CR61","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1158\/1055-9965.EPI-04-0599","volume":"14","author":"AJ Littman","year":"2005","unstructured":"Littman AJ, Jackson LA, Vaughan TL. Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidemiol Biomarker Prev. 2005;14:773\u201378.","journal-title":"Cancer Epidemiol Biomarker Prev"},{"key":"722_CR62","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.ejca.2010.11.003","volume":"47","author":"P Zhan","year":"2011","unstructured":"Zhan P, Suo L-J, Qian Q, Shen X-K, Qiu L-X, Yu L-K, Song Y. \u2018Chlamydia pneumoniae infection and lung cancer risk: a meta-analysis\u2019. Eur J Cancer. 2011;47:742\u201347.","journal-title":"Eur J Cancer"},{"key":"722_CR63","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13027-022-00425-3","volume":"17","author":"NM Premachandra","year":"2022","unstructured":"Premachandra NM, Jayaweera JAAS. Chlamydia pneumoniae infections and development of lung cancer: systematic review. Infect Agents And Cancer. 2022;17:11.","journal-title":"Infect Agents And Cancer"},{"key":"722_CR64","doi-asserted-by":"publisher","first-page":"e0148530","DOI":"10.1371\/journal.pone.0148530","volume":"11","author":"S Khan","year":"2016","unstructured":"Khan S, Imran A, Khan AA, Kalam MA, Alshamsan A. Systems Biology approaches for the prediction of possible role of Chlamydia pneumoniae proteins in the etiology of lung cancer. PLoS One. 2016;11:e0148530.","journal-title":"PLoS One"},{"key":"722_CR65","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","volume":"176","author":"C Jin","year":"2019","unstructured":"Jin C, Lagoudas GK, Zhao C, Bullman S, Bhutkar A, Hu B, Ameh S, Sandel D, Liang XS, Mazzilli S, Whary MT, Meyerson M, Germain R, Blainey PC, Fox JG, Jacks T. \u2018Commensal microbiota promote lung cancer development via \u03b3\u03b4 T cells\u2019. Cell. 2019;176:998\u20131013.e16.","journal-title":"Cell"},{"key":"722_CR66","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","volume":"8","author":"JC Roa","year":"2022","unstructured":"Roa JC, Garc\u00eda P, Kapoor VK, Maithel SK, Javle M, Koshiol J. Gallbladder cancer. Nat Rev. Disease Primers. 2022;8:69.","journal-title":"Nat Rev. Disease Primers"},{"key":"722_CR67","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/ijc.21683","volume":"118","author":"G Randi","year":"2006","unstructured":"Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591\u2013602.","journal-title":"Int J Cancer"},{"key":"722_CR68","first-page":"524","volume":"9","author":"M Tewari","year":"2010","unstructured":"Tewari M, Mishra RR, Shukla HS. Salmonella typhi and gallbladder cancer: report from an endemic region. Hepatobiliary Pancreat Dis Int: HBPD Int. 2010;9:524\u201330.","journal-title":"Hepatobiliary Pancreat Dis Int: HBPD Int"},{"key":"722_CR69","doi-asserted-by":"publisher","first-page":"509","DOI":"10.31557\/APJCP.2021.22.2.509","volume":"22","author":"R Shukla","year":"2021","unstructured":"Shukla R, Shukla P, Behari A, Khetan D, Chaudhary RK, Tsuchiya Y, Ikoma T, Asai T, Nakamura K, Kapoor VK. Roles of Salmonella typhi and Salmonella paratyphi in gallbladder cancer development. Asian Pac J Cancer Prev: APJCP. 2021;22:509\u201316.","journal-title":"Asian Pac J Cancer Prev: APJCP"},{"key":"722_CR70","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1002\/cam4.915","volume":"5","author":"J Koshiol","year":"2016","unstructured":"Koshiol J, Wozniak A, Cook P, Adaniel C, Acevedo J, Az\u00f3car L, Hsing AW, Roa JC, Pasetti MF, Miquel JF, Levine MM, Catterina Ferreccio, and the Gallbladder Cancer Chile Working Group. Salmonella enterica serovar Typhi and gallbladder cancer: a case-control study and meta-analysis. Cancer Med. 2016;5:3310\u2013235.","journal-title":"Cancer Med"},{"key":"722_CR71","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.3390\/ijms18091887","volume":"18","author":"D Domenico","year":"2017","unstructured":"Domenico D, Gino E, Cavallo I, Pontone M, Toma L, Ensoli F. Biofilm producing Salmonella typhi: chronic colonization and development of gallbladder cancer. Int J Mol Sci. 2017;18:1887.","journal-title":"Int J Mol Sci"},{"key":"722_CR72","doi-asserted-by":"crossref","unstructured":"Haghjoo E, Gal\u00e1n JE. Salmonella typhi encodes a functional cytolethal distending toxin that is delivered into host cells by a bacterial-internalization pathway. Proceedings of the National Academy of Sciences of the United States of America. 2004: 4614\u201319, 101.","DOI":"10.1073\/pnas.0400932101"},{"key":"722_CR73","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.febslet.2010.01.024","volume":"584","author":"X Liu","year":"2010","unstructured":"Liu X, Lu R, Wu S, Sun J. Salmonella regulation of intestinal stem cells through the Wnt\/beta-catenin pathway. FEBS Lett. 2010;584:911\u201316.","journal-title":"FEBS Lett"},{"key":"722_CR74","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.3748\/wjg.v23.i22.3978","volume":"23","author":"A Sharma","year":"2017","unstructured":"Sharma A, Sharma KL, Gupta A, Yadav A, Kumar A. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update. World J Gastroenterol. 2017;23:3978\u201398.","journal-title":"World J Gastroenterol"},{"key":"722_CR75","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s00204-015-1593-7","volume":"90","author":"Q Shi","year":"2016","unstructured":"Shi Q, Haenen GR, Maas L, Arlt VM, Spina D, Vasquez YR, Moonen E, Veith C, Schooten FJV, Godschalk RWL. Inflammation-associated extracellular \u03b2-glucuronidase alters cellular responses to the chemical carcinogen benzo[a]pyrene. Archiv Toxicol. 2016;90:2261\u201373.","journal-title":"Archiv Toxicol"},{"key":"722_CR76","doi-asserted-by":"publisher","first-page":"2514136","DOI":"10.1080\/19490976.2025.2514136","volume":"17","author":"G Tang","year":"2025","unstructured":"Tang G, Millar EKA, Graham PH, Beretov J. Interaction between the breast tumor microenvironment and gut microbiome. Gut Microbes. 2025;17:2514136.","journal-title":"Gut Microbes"},{"key":"722_CR77","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13073-021-00874-2","volume":"13","author":"A Tzeng","year":"2021","unstructured":"Tzeng A, Sangwan N, Jia M, Liu C-C, Keslar KS, Downs-Kelly E, Fairchild RL, Al-Hilli Z, Grobmyer SR, Eng C. Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer. Genome Med. 2021;13:60.","journal-title":"Genome Med"},{"key":"722_CR78","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13058-023-01677-6","volume":"25","author":"R German","year":"2023","unstructured":"German R, Marino N, Hemmerich C, Podicheti R, Rusch DB, Stiemsma LT, Gao H, Xuei X, Rockey P, Storniolo AM. Exploring breast tissue microbial composition and the association with breast cancer risk factors. Breast Cancer Res. 2023;25:82.","journal-title":"Breast Cancer Res"},{"key":"722_CR79","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3390\/cells8121642","volume":"8","author":"S Parida","year":"2019","unstructured":"Parida S, Sharma D. The microbiome-estrogen connection and breast cancer risk. Cells. 2019;8:1642.","journal-title":"Cells"},{"key":"722_CR80","doi-asserted-by":"crossref","unstructured":"Jaye K, Chang D, Li CG, Bhuyan DJ. Gut metabolites and breast cancer: the continuum of dysbiosis, breast cancer risk, and potential breast cancer therapy. Int J Mol Sci. 2022;23.","DOI":"10.3390\/ijms23169490"},{"key":"722_CR81","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3390\/metabo14120683","volume":"14","author":"R Mir","year":"2024","unstructured":"Mir R, Albarqi SA, Albalawi W, Alatwi HE, Alatawy M, Bedaiwi RI, Almotairi R, Husain E, Zubair M, Alanazi G, Alsubaie SS, Alghabban RI, Alfifi KA, Bashir S. Emerging role of gut microbiota in breast cancer development and its Implications in treatment. Metabolites. 2024;14:683.","journal-title":"Metabolites"},{"key":"722_CR82","doi-asserted-by":"crossref","unstructured":"Gamba G, Colonetti T, Uggioni MLR, Elibio LU, Balbinot EL, Heinzen R, Macedo ACL, Grande AJ, da Rosa MI. \u2018Gut microbiota and breast cancer: systematic review and meta-analysis\u2019, breast cancer. Vol. 32. Tokyo, Japan; 2025. p. 242\u201357.","DOI":"10.1007\/s12282-024-01658-3"},{"key":"722_CR83","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00432-025-06338-z","volume":"151","author":"M Kwa","year":"2025","unstructured":"Kwa M, Hussey G, Novik Y, Franke AA, Volkova A, Flores K, Blaser MJ, Speyer J, Oratz R, Meyers M, Jhaveri K, Fadel E, Heguy A, Schluter J, Ruggles KV, Adams S. Evaluation of the gut microbiome and sex hormones in postmenopausal women with newly diagnosed hormone receptor-positive breast cancer versus healthy women: a prospective case-control study. J Cancer Res And Clin Oncol. 2025;151:275.","journal-title":"J Cancer Res And Clin Oncol"},{"key":"722_CR84","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1128\/MCB.05734-11","volume":"31","author":"HS Sun","year":"2011","unstructured":"Sun HS, Wilde A, Harrison RE. Chlamydia trachomatis inclusions induce asymmetric cleavage furrow formation and ingression failure in host cells. Mol And Cellular Biol. 2011;31:5011\u201322.","journal-title":"Mol And Cellular Biol"},{"key":"722_CR85","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0167-4889(02)00264-1","volume":"1592","author":"W Voos","year":"2002","unstructured":"Voos W, R\u00f6ttgers K. Molecular chaperones as essential mediators of mitochondrial biogenesis. Biochim et Biophys Acta (BBA) - Mol Cell Res. 2002;1592:51\u201362.","journal-title":"Biochim et Biophys Acta (BBA) - Mol Cell Res"},{"key":"722_CR86","first-page":"38","volume":"12","author":"Y-C Luo","year":"2025","unstructured":"Luo Y-C, Huang X-T, Wang R, Lin Y-J, Sun J-X, Li K-F, Wang D-Y, Yan Y, Qiao Y-K. Advancements in understanding tumor-resident bacteria and their application in cancer therapy. Mil Med Res. 2025;12:38.","journal-title":"Mil Med Res"},{"key":"722_CR87","doi-asserted-by":"crossref","unstructured":"Plewa P, Kie\u0142bowski K, Mentel O, Figiel K, Bakinowska E, Becht R, Banach B, Pawlik A. Bacteria and carcinogenesis and the management of cancer: a narrative review. Pathogens (Basel, Switzerland); 2025. p. 14.","DOI":"10.3390\/pathogens14050509"},{"key":"722_CR88","doi-asserted-by":"publisher","first-page":"118559","DOI":"10.1016\/j.biopha.2025.118559","volume":"192","author":"M Jayaprakash","year":"2025","unstructured":"Jayaprakash M, Kumar DV, Chakraborty G, Chakraborty A, Kumar V. Bacteria-mediated cancer therapy (BMCT): therapeutic applications, clinical insights, and the microbiome as an emerging hallmark of cancer. Biomed Pharmacother. 2025;192:118559.","journal-title":"Biomed Pharmacother"},{"key":"722_CR89","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12964-024-01622-w","volume":"22","author":"A Yarahmadi","year":"2024","unstructured":"Yarahmadi A, Zare M, Aghayari M, Afkhami H, Jafari GA. Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for future. Cell Commun And Signaling. 2024;22:239.","journal-title":"Cell Commun And Signaling"},{"key":"722_CR90","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3390\/immuno4040026","volume":"4","author":"HF Hetta","year":"2024","unstructured":"Hetta HF, Ramadan YN, Alharbi AA, Alsharef S, Alkindy TT, Alkhamali A, Albalawi AS, Amin HE. Gut microbiome as a target of intervention in inflammatory bowel disease pathogenesis and therapy. Immuno. 2024;4:400\u201325.","journal-title":"Immuno"},{"key":"722_CR91","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s43094-025-00825-3","volume":"11","author":"YN Ramadan","year":"2025","unstructured":"Ramadan YN, Rashed ZI, Ahmed R, Salem HA, Alshareef H, Ahmad-Abakur EH, Alanazi FE, Elfadil H, Hetta HF. Bacteriophages: unlocking a new frontier in breast cancer management by defeating oncogenic bacteria. Future J Pharm Sci. 2025;11:74.","journal-title":"Future J Pharm Sci"},{"key":"722_CR92","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1038\/s41591-024-03153-w","volume":"30","author":"KF Pan","year":"2024","unstructured":"Pan KF, Li WQ, Zhang L, Liu WD, Ma JL, Zhang Y, Ulm K, Wang JX, Zhang L, Bajbouj M, Zhang LF, Li M, Vieth M, Quante M, Wang LH, Suchanek S, Mej\u00edas-Luque R, Xu HM, Fan XH, Han X, Liu ZC, Zhou T, Guan WX, Schmid RM, Gerhard M, Classen M, You WC. Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial. Nat Med. 2024;30:3250\u201360.","journal-title":"Nat Med"},{"key":"722_CR93","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1053\/j.gastro.2024.12.033","volume":"169","author":"AC Ford","year":"2025","unstructured":"Ford AC, Yuan Y, Park JY, Forman D, Moayyedi P. Eradication therapy to prevent gastric cancer in <em & amp;#x003E;Helicobacter <\/em> <em>pylori<\/em>-positive individuals: systematic review and meta-analysis of randomized controlled trials and observational studies. Gastroenterology. 2025;169:261\u201376.","journal-title":"Gastroenterology"},{"key":"722_CR94","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1001\/jama.2024.14887","volume":"332","author":"YC Lee","year":"2024","unstructured":"Lee YC, Chiang TH, Chiu HM, Su WW, Chou KC, Chen SL, Yen AM, Fann JC, Chiu SY, Chuang SL, Chen YR, Chen SD, Hu TH, Fang YJ, Wu MS, Chen TH, Yeh YP. Screening for Helicobacter pylori to prevent gastric cancer: a pragmatic randomized Clinical trial. Jama. 2024;332:1642\u201351.","journal-title":"Jama"},{"key":"722_CR95","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1136\/gutjnl-2020-320839","volume":"69","author":"AC Ford","year":"2020","unstructured":"Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut. 2020;69:2113\u201321.","journal-title":"Gut"},{"key":"722_CR96","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1002\/cam4.2277","volume":"8","author":"Y Uno","year":"2019","unstructured":"Uno Y. Prevention of gastric cancer by Helicobacter pylori eradication: a review from Japan. Cancer Med. 2019;8:3992\u20134000.","journal-title":"Cancer Med"},{"key":"722_CR97","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/apt.12655","volume":"39","author":"V Nagaraja","year":"2014","unstructured":"Nagaraja V, Eslick GD. Systematic review with meta-analysis: the relationship between chronic Salmonella typhi carrier status and gall-bladder cancer. Aliment Pharmacol Ther. 2014;39:745\u201350.","journal-title":"Aliment Pharmacol Ther"},{"key":"722_CR98","doi-asserted-by":"publisher","first-page":"217621","DOI":"10.1016\/j.canlet.2025.217621","volume":"618","author":"AK Pragasam","year":"2025","unstructured":"Pragasam AK, Maurya S, Jain K, Pal S, Raja C, Yadav R, Kumar S, Purohit A, Pradhan D, Kajal K, Talukdar D, Singh AN, Verma J, Jana P, Rawat S, Kshetrapal P, Krishna A, Kumar S, Bansal VK, Das B, Srikanth CV, Garg PK. Invasive Salmonella typhimurium colonizes gallbladder and contributes to gallbladder carcinogenesis through activation of host epigenetic modulator KDM6B. Cancer Lett. 2025;618:217621.","journal-title":"Cancer Lett"},{"key":"722_CR99","doi-asserted-by":"crossref","unstructured":"Rahmati R, Zarimeidani F, Boroujeni MRG, Sadighbathi S, Kashaniasl Z, Saleh M, Alipourfard I. CRISPR-Assisted probiotic and in situ engineering of gut microbiota: a prospect to modification of metabolic disorders. Probiotics And Antimicrob Proteins. 2025.","DOI":"10.1007\/s12602-025-10561-y"},{"key":"722_CR100","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s40164-024-00570-y","volume":"13","author":"X Feng","year":"2024","unstructured":"Feng X, Li Z, Liu Y, Chen D, Zhou Z. CRISPR\/Cas9 technology for advancements in cancer immunotherapy: from uncovering regulatory mechanisms to therapeutic applications. Exp Hematol Oncol. 2024;13:102.","journal-title":"Exp Hematol Oncol"},{"key":"722_CR101","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1186\/s13287-025-04723-6","volume":"16","author":"M Dashti","year":"2025","unstructured":"Dashti M, Sarab MM, Shad F, Dehnavi S. CRISPR-mediated engineering of mesenchymal stromal\/stem cells: a summary of recent progress in immunological applications for regenerative medicine and cancer therapy. STEM Cell Res Ther. 2025;16:592.","journal-title":"STEM Cell Res Ther"},{"key":"722_CR102","doi-asserted-by":"publisher","first-page":"LB062","DOI":"10.1158\/1538-7445.AM2021-LB062","volume":"81","author":"D Davar","year":"2021","unstructured":"Davar D, Dzutsev A, McCulloch JA, Rodrigues RR, Chauvin J-M, Morrison RM, Deblasio RN, Menna C, Ding Q, Pagliano O. Abstract LB062: efficacy of responder-derived fecal microbiota transplant (R-FMT) and pembrolizumab in anti-PD-1 refractory patients with advanced melanoma. Cancer Res. 2021;81:LB062\u201362.","journal-title":"Cancer Res"},{"key":"722_CR103","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12866-022-02465-6","volume":"22","author":"CM Doocey","year":"2022","unstructured":"Doocey CM, Finn K, Murphy C, Guinane CM. The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development. BMC Microbiol. 2022;22:53.","journal-title":"BMC Microbiol"},{"key":"722_CR104","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/nm.2015","volume":"15","author":"S Wu","year":"2009","unstructured":"Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, Housseau F, Pardoll DM, Sears CL. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009;15:1016\u201322.","journal-title":"Nat Med"},{"key":"722_CR105","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/15384101.2024.2309005","volume":"23","author":"J Yang","year":"2024","unstructured":"Yang J, Wang X, Hu T, Huang H, Chen G, Jin B, Zeng G, Liu J. Entero-toxigenic Bacteroides fragilis contributes to intestinal barrier injury and colorectal cancer progression by mediating the BFT\/STAT3\/ZEB2 pathway. Cell Cycle. 2024;23:70\u201382.","journal-title":"Cell Cycle"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-025-00722-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00722-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00722-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:17:45Z","timestamp":1781626665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13027-025-00722-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["722"],"URL":"https:\/\/doi.org\/10.1186\/s13027-025-00722-7","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"12 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared no competing interests to be disclosed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"11"}}